v. 14 – 2020/02
|Market Executive Summary||
Initial implementation phase: 2019-2020
The start is postponed until the 1st of Nov, 2020.
Non-serialized medicines, put into circulation before the deadline, will remain until their expiration.
Following the re-orientation of the program earlier in the year, the current status is an ongoing debate about the preferred model (use of cryptocode vs. EU-FMD style coding) with a likely preference to follow EU-FMD example.